Notice ID: 4bbf86fb508c44a5a6c6e1b15beefc5eJustificationAwardedArchived
Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)
Awarded on September 26, 2025. Full description on SAM.gov.
Overview
- Posted
- October 15, 2025
- Notice type
- Justification
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- ASPR/ORM-SNS
- Place of performance
- Reston, Virginia
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Nov 7, 2026
- First published
- Last updated on SAM.gov
- Award date
- Sep 26, 2025
- Award amount (SAM.gov award notice)
- Not specified
Identifiers
- Solicitation number
- 75A50325Q00021
- Notice ID
- 4bbf86fb508c44a5a6c6e1b15beefc5e
Description
Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)
Award Overview
Award Number
GS00F022CA
Award Amount (SAM.gov award notice)
Not specified
Award Date
Sep 26, 2025
Awardee
Not specified
Delivery Order Number
75A50325F80036
Original Solicitation
Notice ID: 4bbf86fb508c44a5a6c6e1b15beefc5e
Posted Date: Oct 15, 2025
Original Response Deadline: Not specified
Contract Details
No FPDS record matches this award number at the same department yet
Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.
Contacts
Contracting Officer
Primary Contact
Leatrice Bulls
Secondary Contact
Kimberly Golden
Documents
Files (1)
- Download
Limited_Sources_Justification (LSJ)_XOFLUZA_Redacted.pdf
846 KBAdded in Justification version 3Posted
Lifecycle
- 3Version 3JustificationArchivedCurrent
Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)
Similar Opportunities
Additional Details
Solicitation Number
75A50325Q00021
Archive Date
Nov 14, 2025
Office Address
Atlanta, GA, 30341